Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
Journal Title: Український журнал медицини, біології та спорту - Year 2017, Vol 6, Issue 4
Abstract
Metabolic syndrome which is accompanied by excess body weight is a predictor of ischemic myocardial defeat in ischemic heart disease (IHD) and non-alcoholic fatty liver disease (NAFLD). Among the medicines that provide the normalization of metabolic status, correcting dyslipidemia, we would like to emphasize levocarnitine, which has anabolic effect, reduces the main metabolism, and has antihypoxic, lipid metabolism stimulating pharmacological effect. The purpose of the study is to determine the effect of levocarnitine on the progression of IHD in combination with NAFLD and obesity. Materials and methods. The surveyed patients (68 patients with an average age of 70.32 ± 6.71 years, 0.90 (M ± SEM; SD)) were divided into two groups: the main group and the comparison group. The main group consisted of 35 patients who received levocarnitine at a dose of 20 mg/kg/day intravenously for 10 days during the period of stay in the hospital, and subsequently on the stage of outpatient treatment continued the therapy per os – 1g 2 twice a day at the background of the standard IHD pharmacotherapy for another 21 days. The control group consisted of 33 patients who received exclusively standard IHD therapy. In both groups, in addition to the general clinical trial, daily monitoring of the ECG was performed (before and after 1 month of treatment) using the Holter system "LABTECH Ltd", software version V4.04.RC14), determination of lipidogram indicators (total chol esterol level (TCL), Triglycerides (TG), low-density lipoprotein (LDL-C) and high density (HDL-C), an atherogenicity index (AI)). The presence of NAFLD (fatty liver infiltration) was diagnosed with ultrasound examination of the abdominal organs on the Logiq F8 («General Electric») apparatus. Results and discussions. As a result of the study, significant decrease in the number of episodes and duration of ischemia periods per day in all patients and a tendency to decrease of cardiac rhythm disturbance in the background of treatment with a significant advantage in the group receiving additionally levocarnitine was noticed.
Authors and Affiliations
T. Shevchenko, S. Sorokina, I. Kudrya, O. Shaposhnyk
Keywords
Related Articles
- EP ID EP273387
- DOI -
- Views 92
- Downloads 0
Ways to Improve Foreign Students’ Educational Process at the Department of Histology, Cytology and Embryology, IFNMU
Nowadays the rapid progress in the sphere of medicine stimulates faster development of medical education in Ukraine. Due to this reason one of the priority tasks for the Ivano-Frankivsk National Medical University is to...
ОСОБЛИВОСТІ ТОНУСУ ТА РЕАКТИВНОСТІ ВЕГЕТАТИВНОЇ НЕРВОВОЇ СИСТЕМИ У ХВОРИХ НА ПСОРІАЗ КУРЦІВ ТЮТЮНУ
Метою роботи було встановити вплив куріння на перебіг псоріазу за даними вивчення тонусу і реактивності вегетативної нервової системи у хворих на псоріаз курців тютюну. Обстежено 85 хворих на псоріаз у віці 25-55 років (...
Main Vectors of Medical Rehabilitation in Diaphyseal Fractures Treatment
Current study is based on a retrospective analysis of 68 patients treated at the traumatology clinic of Transkarpathian Regional Clinical Hospital named after A. Novak between 2015 and 2017. Their diagnosis was diaphysea...
Results of Gel Implantation of Hyaluronic Acid under Mucous Balanus for Treatment of Early Ejaculation
Early (rapid) ejaculation is widespread problem which decreases sexual satisfaction and selfestimation of men and it can be the main factor of sexual disharmony of the couple. Patients require minimally invasive methods...
ВПЛИВ АНТИОКСИДАНТІВ НА СТАН КРІОКОНСЕРВОВАНИХ ЯДРОВМІСНИХ КЛІТИН КОРДОВОЇ КРОВІ ЛЮДИНИ ПІСЛЯ ПЕРЕНЕСЕННЯ ЇХ ДО УМОВ, ЩО МОДЕЛЮЮТЬ ФІЗІОЛОГІЧНІ
У роботі проведено порівняльний аналіз ефективності кріопротекторних сумішей, що містять різні концентрації проникаючого кріопротектора ДМСО та антиоксидантів, при кріоконсервуванні ядровмісних клітин кордової крові та п...